%20(2).jpg)
SAGEIQ
The ability to source and complete successful transactions in the life sciences space is critically dependent on in depth market analysis on a global basis. Sage recognised the need for advanced research tools to ensure that no stone is left unturned. Recent availability of AI-powered methodology has enabled Sage to employ a suite of new proprietary tools to assist in this area, and this inhouse capability is called SAGEIQ.
​
A leading advisory firm, PwC, has commented:
​"Deal-making success will increasingly depend on advanced analytics and AI capabilities to evaluate scientific, commercial, and competitive potential with precision.” - PwC Global Pharma & Life Sciences Outlook
The Sage Group has launched SAGEIQ for the benefit of its clients - a new range of capabilities for transactional advisory services using a novel offering of carefully curated, AI-powered research agents. The Sage AI Search Engine (SAGEIQ) builds on Sage's extensive experience in healthcare and life science deal making, which we have been using for over 30 years to help clients monetize and commercialise their assets. We have worked with leading industry experts to formulate SAGEIQ in the context of our client's need for strategic transactions including M&A and licensing in/out.
We show in the graph below some top level performance metrics for SAGEIQ. This illustrates the number of search results for SAGEIQ compared to conventional search engines, demonstrating superior performance in output for SAGEIQ. In this case, the search output was qualified targets in a specific therapeutic target scenario.
We would be pleased to arrange a one on one meeting to demonstrate the unparalleled power that the SAGEIQ brings to the services we can offer you. This enables a depth of analytical insight into potential partners (from large to small) globally which has heretofore not been possible; and provides our clients greatly expanded targeting capabilities to optimise identification and closing of strategic transactions in pharmaceuticals, diagnostics and medtech.
​
Of course, nothing can replace the commercial deal-making expertise of Sage, acquired over many years of hands-on experience with hundreds of clients and transactions. But SAGEIQ has empowered Sage to offer a new generation of market analytical approaches which is unparalleled in our sector, and able to provide a unique set of insights into commercial targets both above and below the radar screen on a global basis.
​​